Skip to content
The Policy VaultThe Policy Vault

Lumigan (bimatoprost 0.01% ophthalmic solution)Medica

Ocular hypertension

Initial criteria

  • Patient has ocular hypertension OR open-angle glaucoma (including normal-tension glaucoma).

Reauthorization criteria

  • Same as initial criteria.

Approval duration

1 year